Literature DB >> 1512223

Biological activity of a proteoglycan form of macrophage colony-stimulating factor and its binding to type V collagen.

S Suzu1, T Ohtsuki, M Makishima, N Yanai, T Kawashima, N Nagata, K Motoyoshi.   

Abstract

Two different types of macrophage colony-stimulating factors (M-CSF) were found, one with an apparent molecular mass of 85 kDa and the other greater than 200 kDa. The high molecular mass M-CSF was identified as a proteoglycan carrying chondroitin sulfate glycosaminoglycan and was designated as the proteoglycan form of M-CSF (PG-M-CSF). In this study, we compared the biological activity of the 85-kDa M-CSF and PG-M-CSF and examined the binding properties of these two M-CSF to certain extracellular matrix proteins, i.e. types I-V collagen and fibronectin, using a modified enzyme-linked immunosorbent assay. PG-M-CSF was capable of supporting the formation of murine macrophage colonies, and pretreatment of PG-M-CSF with chondroitinase AC, which degrades chondroitin sulfate, did not alter its colony-stimulating activity. The specific activity of PG-M-CSF was similar to that of the 85-kDa M-CSF. The 85-kDa M-CSF had no apparent affinity for the extracellular matrix proteins examined, whereas PG-M-CSF had an appreciable binding capacity to type V collagen, but did not bind to types I, II, III, and IV collagen or to fibronectin. Pretreatment of PG-M-CSF with chondroitinase AC completely abolished the binding of the species to type V collagen. Addition of exogenous chondroitin sulfate inhibited the binding of PG-M-CSF to type V collagen in a dose-dependent manner. These data indicated that the interaction between PG-M-CSF and type V collagen was mediated by the chondroitin sulfate chain of PG-M-CSF. PG-M-CSF bound to type V collagen could stimulate the proliferation of bone marrow macrophages, indicating that the matrix protein-bound PG-M-CSF retained its biological activity. This interaction between PG-M-CSF and type V collagen implies that the role of PG-M-CSF may be distinct from that of 85-kDa M-CSF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512223

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Distinct roles of CSF-1 isoforms in lupus nephritis.

Authors:  Julia Menke; Yasunori Iwata; Whitney A Rabacal; Ranu Basu; E Richard Stanley; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

2.  Developmental and functional significance of the CSF-1 proteoglycan chondroitin sulfate chain.

Authors:  Sayan Nandi; Mohammed P Akhter; Mark F Seifert; Xu-Ming Dai; E Richard Stanley
Journal:  Blood       Date:  2005-10-06       Impact factor: 22.113

3.  Proteoglycan form of macrophage colony-stimulating factor binds low density lipoprotein.

Authors:  S Suzu; T Inaba; N Yanai; T Kawashima; N Yamada; T Oka; R Machinami; T Ohtsuki; F Kimura; S Kondo
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

4.  Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA.

Authors:  Ho-Hyung Woo; Terri Baker; Csaba Laszlo; Setsuko K Chambers
Journal:  Mol Cell Proteomics       Date:  2013-03-07       Impact factor: 5.911

5.  Immunohistochemical identification of proteoglycan form of macrophage colony-stimulating factor on bone surface.

Authors:  T Ohtsuki; K Hatake; S Suzu; K Saito; K Motoyoshi; Y Miura
Journal:  Calcif Tissue Int       Date:  1995-09       Impact factor: 4.333

6.  Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152.

Authors:  Ho-Hyung Woo; Csaba F László; Stephen Greco; Setsuko K Chambers
Journal:  Mol Cancer       Date:  2012-08-21       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.